IO Biotech (IOBT)
NASDAQ:IOBT
US Market

IO Biotech (IOBT) Technical Analysis

Compare
326 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
0Neutral
9Bearish
Technical Analysis Consensus
Strong Buy
1Bullish
0Neutral
0Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
IO Biotech’s (IOBT) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting IO Biotech is a Sell.
IO Biotech’s (IOBT) 20-Day exponential moving average is 1.02, while IO Biotech’s (IOBT) share price is $0.98, making it a Sell.
IO Biotech’s (IOBT) 50-Day exponential moving average is 0.98, while IO Biotech’s (IOBT) share price is $0.98, making it a Buy.

IO Biotech (IOBT) Pivot Points

Apr 06, 2025, 05:34 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.88
0.96
1.03
1.11
1.18
1.26
1.32
Fibonacci
0.96
1.02
1.06
1.11
1.17
1.20
1.26
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

IO Biotech (IOBT) Moving Averages

Apr 06, 2025, 05:34 PM
Period
Simple
Exponential
MA5
1.03Sell
1.03Sell
MA10
1.08Sell
1.04Sell
MA20
0.99Sell
1.02Sell
MA50
0.97Buy
0.98Buy
MA100
0.92Buy
0.98Sell
MA200
1.07Sell
1.10Sell
IO Biotech’s (IOBT) 10-Day exponential moving average is 1.04, while IO Biotech’s (IOBT) share price is $0.98, making it a Sell.
IO Biotech’s (IOBT) 100-Day exponential moving average is 0.98, while IO Biotech’s (IOBT) share price is $0.98, making it a Sell.
IO Biotech’s (IOBT) stock price is $0.98 and IO Biotech’s (IOBT) 50-day simple moving average is 0.97, creating a Buy signal.
IO Biotech’s (IOBT) stock price is $0.98 and IO Biotech’s (IOBT) 100-day simple moving average is 0.92, creating a Buy signal.
IO Biotech’s (IOBT) stock price is $0.98 and IO Biotech’s (IOBT) 200-day simple moving average is 1.07, creating a Sell signal.

IO Biotech (IOBT) Technical Indicators

Apr 06, 2025, 05:34 PM
Name
Value
Implied Action
RSI (14)
50.01
Neutral
STOCH (9,6)
40.67
Neutral
STOCHRSI (14)
44.70
Neutral
MACD (12,26)
0.04
Sell
ADX (14)
28.39
Neutral
Williams %R
-72.50
Buy
CCI (14)
34.37
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
39.80
Neutral
ROC
6.52
Buy
IO Biotech’s (IOBT) Relative Strength Index (RSI) is 50.01, creating a Neutral signal.
IO Biotech’s (IOBT) Trend Strength Indicator (ADX) is 28.39, creating a Neutral signal.
IO Biotech’s (IOBT) Commodity Channel Index (CCI) is 34.37, creating a Neutral signal.
IO Biotech’s (IOBT) Price Rate of Change (ROC) is 6.52, creating a Buy signal.

FAQ

Is IOBT a Buy, Hold, or Sell?
Based on IOBT’s technical indicators, IOBT is a Sell.
    What is IOBT’s RSI (14)?
    IOBT’s RSI (14) is 50.01, which suggests IOBT is a Neutral.
      What is IOBT’s MACD?
      IOBT’s MACD is 0.04, which suggests IOBT is a Sell.
        What is IOBT’s 5-day moving average?
        IOBT’s 5-day moving average is 1.03, which suggests IOBT is a Sell.
          What is IOBT’s 20-day moving average?
          IOBT 20-day moving average is 0.99, which suggests IOBT is a Sell.
            What is IOBT’s 50-day moving average?
            IOBT’s 50-day moving average is 0.97, which suggests IOBT is a Buy.
              What is IOBT’s 200-day moving average?
              IOBT’s 200-day moving average is 1.07, which suggests IOBT is a Sell.
                What is IOBT’s Williams % R (14)?
                IOBT’s Williams % R (14) is -72.50, which suggests IOBT is a Buy.
                  What is IOBT’s CCI (14)?
                  IOBT’s CCI (14) is 34.37, which suggests IOBT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis